1. Search Result

Search Result

Results for "111358-88-4" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-50867

    CEP-701; KT-5555

    JAK FLT3 Trk Receptor Cancer
    Lestaurtinib (CEP-701;KT-5555) is an ATP-competitive multi-kinase inhibitor with potent activity against the Trk family of receptor tyrosine kinases. Lestaurtinib inhibits JAK2, FLT3 and TrkA with IC50s of 0.9, 3 and less than 25 nM, respectively.